.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. the family of an elderly woman found dead on the floor of a hospital ward have said staff at altnagelvin denied her her dignity and prevented them from saying a final goodbye.
.
.
.
.
.